Author:
Juric Dejan,Castel Pau,Griffith Malachi,Griffith Obi L.,Won Helen H.,Ellis Haley,Ebbesen Saya H.,Ainscough Benjamin J.,Ramu Avinash,Iyer Gopa,Shah Ronak H.,Huynh Tiffany,Mino-Kenudson Mari,Sgroi Dennis,Isakoff Steven,Thabet Ashraf,Elamine Leila,Solit David B.,Lowe Scott W.,Quadt Cornelia,Peters Malte,Derti Adnan,Schegel Robert,Huang Alan,Mardis Elaine R.,Berger Michael F.,Baselga José,Scaltriti Maurizio
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012)
2. Swanton, C. Intratumor heterogeneity: evolution through space and time. Cancer Res. 72, 4875–4882 (2012)
3. Juric, D. BYL719, a next generation PI3K alpha specific inhibitor: preliminary safety, PK, and efficacy results from the first-in-human study. Cancer Res. 72, Abstr. CT-01 (2012)
4. Engelman, J. A., Luo, J. & Cantley, L. C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nature Rev. Genet. 7, 606–619 (2006)
5. Cantley, L. C. The phosphoinositide 3-kinase pathway. Science 296, 1655–1657 (2002)
Cited by
474 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献